Based on your previous selection, you have been forwarded to the website for International.

Cancer Genet. Cytogenet., 142, 80- 82
2003

Cytogenetic and molecular characterization of simultaneous chronic and acute myelotic leukemia.

L. Harder, S. Gesk, J.I. Martin-Subero, H. Merz, A. Hochhaus, E. Maa\ss, A. Feller, W. Grote, R. Siebert, S. Fetscher

We describe a patient initially diagnosed with a chronic myeloproliferative disorder in the accelerated phase. Cytogenetic analysis showed the presence of two independent clones. One clone contained a typical Philadelphia (Ph) chromosome due to t(9;22)(q34;q11), as the sole abnormality which was proven molecularly to result in the b2a2-BCR/ABL fusion. The other clone displayed a complex karyotype with several structural and numerical aberrations including trisomy 11 and 22 but lacking a t(9;22) or any other structural abnormalities involving chromosomes 9 and 22. Fluorescence in situ hybridization demonstrated that the t(9;22) was present only in cells with two copies of chromosomes 11 and 22. In contrast, cells with trisomies 11 and 22 lacked evidence for a BCR/ABL fusion. Based on the genetic findings, simultaneous chronic and acute myelocytic leukemias were diagnosed rather than a blastic phase of a chronic myelocytic leukemia.

All Publications